GSA Capital Partners’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,431
| Closed | -$80K | – | 1499 |
|
|
2022
Q3 | $80K | Buy |
+9,431
| New | +$80K | 0.01% | 1387 |
|
|
2021
Q3 | – | Sell |
-646
| Closed | -$60K | – | 1457 |
|
|
2021
Q2 | $60K | Buy |
646
+94
| +17% | +$8.73K | 0.01% | 1271 |
|
|
2021
Q1 | $29K | Sell |
552
-6,821
| -93% | -$358K | ﹤0.01% | 1040 |
|
|
2020
Q4 | $199K | Buy |
7,373
+6,509
| +753% | +$176K | 0.03% | 995 |
|
|
2020
Q3 | $24K | Sell |
864
-4,696
| -84% | -$130K | ﹤0.01% | 1212 |
|
|
2020
Q2 | $80K | Buy |
+5,560
| New | +$80K | 0.04% | 507 |
|
|
2020
Q1 | – | Sell |
-739
| Closed | -$15K | – | 1089 |
|
|
2019
Q4 | $15K | Buy |
+739
| New | +$15K | ﹤0.01% | 1384 |
|
|
2017
Q2 | – | Sell |
-4,695
| Closed | -$207K | – | 1695 |
|
|
2017
Q1 | $207K | Buy |
+4,695
| New | +$207K | 0.01% | 1555 |
|